AbbVie <ABBV.N>: UBS raises target price to $260 from $230
ABBV•Related News
OneMedNet announces annual shareholder meeting
ONMD•
Avalon Holdings Q2 FY26 net income rises to $0.9 million; net operating revenues increase to $20.9 million
AWX•
Capital Southwest adds RBC Capital Markets to $2 billion at-the-market equity program
CSWC•
Gevo CFO Agiri Oluwagbemileke Yusuf sells 18,223 shares worth $28,037.14
GEVO•
Expion360 Q2 gross margin rises as product mix shifts to higher-margin items
XPON•